InspireMD, Inc.
corporate_fare Company Profile
InspireMD, Inc. (NASDAQ:NSPR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 31 items for NSPR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for NSPR spans 8-K, 424B5, 4/A, 10-Q.
Recent high-impact activity:
- InspireMD's Underwriters Exercise Full Greenshoe, Adding ~$5.3M and 8.6M Shares to November Offering
- $37.5M Offering Priced With Warrants Covering 93.6M Shares — Massive Dilution for InspireMD
- InspireMD Files Preliminary Prospectus for Stock-and-Warrant Offering Led by Lake Street
- InspireMD Q3 Revenue Falls 11.1% to $2.24M; Cash Drops to $19.2M Ahead of TCAR Launch
- InspireMD Launches Public Offering of Stock and Warrants Hours After FDA Win
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 251,530 shares in NSPR as of the October 30, 2026 settlement, a 210.9% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 62.4% of NSPR volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
High riskFiling-implied dilution signals for NSPR, detected from its recent SEC filings · based on capital-structure filings through 2026-11-20.
Greenshoe Exercised in Full · Additional ~$5.3M in Net Proceeds
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →